On Act No. 287 of 1975 relating to 21 U.S.C. Section 353 (misbranding of drugs) and 21 U.S.C. Section 801 et seq. (controlled substances).

Requested by: Mr. F. Joseph Hodge, Executive Secretary, South Carolina Board of Pharmaceutical Examiners.

Back to Opinions Archive